Observational studyArthritis & rheumatology (Hoboken, N.J.)2015

Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.

Meghna Jani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.